Dual sequencing of the epigenome and genome could have broad implications in oncology.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ehrlich, M. Epigenetics 14, 1141–1163 (2019).
Zhao, S. G. et al. Nat. Genet. 52, 778–789 (2020).
Füllgrabe, J. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01652-0 (2023).
Nachun, D. et al. Aging Cell 20, e13366 (2021).
Carreras-Gallo, N. et al. Commun. Biol. 5, 455 (2022).
Kim, S. T. et al. Cancer Res. 79, 916 (2019).
Alexandrov, L. B. et al. Nature 578, 94–101 (2020).
Locke, W. J. et al. Front. Genet. 10, 1150 (2019).
Guler, G. D. et al. Nat. Commun. 11, 5270 (2020).
Tse, O. Y. O. et al. Proc. Natl Acad. Sci. USA 118, e2019768118 (2021).
Katsman, E. et al. Genome Biol. 23, 158 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.M.C. serves on the scientific advisory board of Tempus and has a financial interest in the company.
Rights and permissions
About this article
Cite this article
George, J.M., Chinnaiyan, A.M. Speed reading the epigenome and genome. Nat Biotechnol 41, 1392–1393 (2023). https://doi.org/10.1038/s41587-023-01757-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01757-0